Leerink Partnrs Has Pessimistic Outlook of THC Q2 Earnings

Tenet Healthcare Co. (NYSE:THC) – Analysts at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for Tenet Healthcare in a research note issued to investors on Wednesday, February 12th. Leerink Partnrs analyst W. Mayo now expects that the company will earn $2.60 per share for the quarter, down from their prior forecast of $2.66. The consensus estimate for Tenet Healthcare’s current full-year earnings is $11.37 per share. Leerink Partnrs also issued estimates for Tenet Healthcare’s Q4 2025 earnings at $3.43 EPS, Q1 2026 earnings at $3.46 EPS, Q2 2026 earnings at $3.27 EPS, Q3 2026 earnings at $3.08 EPS, Q4 2026 earnings at $3.83 EPS, FY2028 earnings at $25.45 EPS and FY2029 earnings at $28.57 EPS.

Other analysts have also recently issued research reports about the company. StockNews.com cut Tenet Healthcare from a “buy” rating to a “hold” rating in a research report on Thursday. Barclays cut their target price on Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating for the company in a research report on Thursday. JPMorgan Chase & Co. restated an “overweight” rating and set a $175.00 price target on shares of Tenet Healthcare in a report on Tuesday, December 17th. Raymond James cut Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 price target for the company. in a report on Friday, November 22nd. Finally, The Goldman Sachs Group cut Tenet Healthcare from a “buy” rating to a “neutral” rating and cut their price target for the company from $196.00 to $140.00 in a report on Monday, December 16th. Four analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $163.19.

Tenet Healthcare Stock Performance

NYSE:THC opened at $133.40 on Friday. The company has a current ratio of 1.58, a quick ratio of 1.52 and a debt-to-equity ratio of 2.35. Tenet Healthcare has a 12-month low of $88.57 and a 12-month high of $171.20. The stock has a 50-day moving average price of $133.32 and a 200 day moving average price of $148.13. The stock has a market capitalization of $12.69 billion, a P/E ratio of 4.27, a P/E/G ratio of 0.63 and a beta of 2.05.

Tenet Healthcare (NYSE:THC) last released its earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a return on equity of 24.05% and a net margin of 14.91%.

Institutional Investors Weigh In On Tenet Healthcare

Institutional investors and hedge funds have recently modified their holdings of the business. New Wave Wealth Advisors LLC bought a new stake in shares of Tenet Healthcare during the 4th quarter worth approximately $343,000. Swedbank AB lifted its stake in shares of Tenet Healthcare by 100.0% during the 4th quarter. Swedbank AB now owns 40,000 shares of the company’s stock worth $5,049,000 after acquiring an additional 20,000 shares during the last quarter. Legacy Capital Group California Inc. bought a new stake in shares of Tenet Healthcare during the 3rd quarter worth approximately $1,055,000. Signet Financial Management LLC bought a new stake in Tenet Healthcare during the 4th quarter valued at $1,526,000. Finally, China Universal Asset Management Co. Ltd. bought a new stake in Tenet Healthcare during the 4th quarter valued at $410,000. 95.44% of the stock is owned by institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.